Search Results

There are 6699 results for: content related to: Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects

  1. You have free access to this content
    Lansoprazole regimens that sustain intragastric pH >6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 985–995, D. C. METZ, F. AMER, B. HUNT, M. VAKILY, M. J. KUKULKA and N. SAMRA

    Article first published online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02850.x

  2. You have free access to this content
    A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue 4, August 2004, Pages: 407–411, J. W. Freston, M. J. Kukulka, E. Lloyd and C. Lee

    Article first published online : 26 JUL 2004, DOI: 10.1111/j.1365-2036.2004.02086.x

  3. You have free access to this content
    A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 11, June 2004, Pages: 1211–1215, D. A. Gremse, J. R. Donnelly, M. J. Kukulka, E. Lloyd and C. Lee

    Article first published online : 19 APR 2004, DOI: 10.1111/j.1365-2036.2004.01940.x

  4. You have free access to this content
    An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 11-12, December 2006, Pages: 1603–1611, J. W. DEVLIN, A. BAKSHI, K. BUNGAY and K. M. OLSEN

    Article first published online : 28 NOV 2006, DOI: 10.1111/j.1365-2036.2006.03169.x

  5. You have free access to this content
    Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 10, May 2004, Pages: 1111–1122, J. W. Freston, B. L. Pilmer, Y.-L. Chiu, Q. Wang, J. C. Stolle, J. S. Griffin and C. Q. Lee

    Article first published online : 29 APR 2004, DOI: 10.1111/j.1365-2036.2004.01942.x

  6. You have free access to this content
    Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 4, April 2000, Pages: 397–406, Gerson, Hatton, Ryono, Jones, Pulliam, Sampliner, Triadafilopoulos and Fass

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00726.x

  7. Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration

    Chirality

    Volume 22, Issue 7, July 2010, Pages: 635–640, Masatomo Miura, Satoru Motoyama, Yudai Hinai, Takenori Niioka, Makoto Hayakari, Jun-Ichi Ogawa and Toshio Suzuki

    Article first published online : 10 DEC 2009, DOI: 10.1002/chir.20810

  8. You have free access to this content
    Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 3, August 2008, Pages: 326–333, K. M. OLSEN and J. W. DEVLIN

    Article first published online : 3 MAY 2008, DOI: 10.1111/j.1365-2036.2008.03728.x

  9. Pediatric drugs—a review of commercially available oral formulations

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 5, May 2008, Pages: 1731–1774, Robert G. Strickley, Quynh Iwata, Sylvia Wu and Terrence C. Dahl

    Article first published online : 6 SEP 2007, DOI: 10.1002/jps.21101

  10. Lansoprazole: A Comprehensive Review

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 2, March-April 1997, Pages: 308–326, Dr. Anthony E. Zimmermann and Dr. Brian G. Katona

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03714.x

  11. You have free access to this content
    Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 7, July 1999, Pages: 959–967, Kovacs, Campbell, Richter, Haber, Jennings and Rose

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00569.x

  12. You have free access to this content
    Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 7, July 2000, Pages: 887–892, Sharma, Peyton, Spears, Raufman and Howden

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00794.x

  13. You have free access to this content
    Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 8, August 2000, Pages: 963–978, C. A. M. Stedman and M. L. Barclay

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00788.x

  14. Effects of Fluvoxamine on Lansoprazole Pharmacokinetics in Relation to CYP2C19 Genotypes

    The Journal of Clinical Pharmacology

    Volume 44, Issue 11, November 2004, Pages: 1223–1229, Dr Norio Yasui-Furukori, Dr Masato Saito, Dr Tsukasa Uno, Dr Takenori Takahata, Dr Kazunobu Sugawara and Dr Tomonori Tateishi

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270004269015

  15. Lessons from two cases of anaphylaxis to proton pump inhibitors

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 614–616, S.-W. Choi, J.-M. Han, Y.-J. Bae, Y. S. Lee, Y. S. Cho, H.-B. Moon and T.-B. Kim

    Article first published online : 30 MAY 2012, DOI: 10.1111/j.1365-2710.2012.01348.x

  16. You have free access to this content
    Dose–response relationship of lansoprazole to gastric acid antisecretory effects

    Alimentary Pharmacology & Therapeutics

    Volume 12, Issue 4, April 1998, Pages: 321–327, Blum, Hunt, Kidd, Shi, Jennings and Greski-Rose

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1365-2036.1998.00306.x

  17. Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

    The Journal of Clinical Pharmacology

    Volume 48, Issue 4, April 2008, Pages: 475–484, Dr David S. Small, Dr Nagy A. Farid, Mr Christopher D. Payne, Dr Govinda J. Weerakkody, Ms Ying G. Li, Dr John T. Brandt, Dr Daniel E. Salazar and Dr Kenneth J. Winters

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008315310

  18. Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes

    Chirality

    Volume 17, Issue 6, 2005, Pages: 338–344, Masatomo Miura, Hitoshi Tada, Norio Yasui-Furukori, Tsukasa Uno, Kazunobu Sugawara, Tomonori Tateishi and Toshio Suzuki

    Article first published online : 26 APR 2005, DOI: 10.1002/chir.20159

  19. You have free access to this content
    Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 6, June 1999, Pages: 827–832, K. D. Bardhan, J. Crowe, R. P. H. Thompson, P. N. Trewby, P. N. Keeling, D. Weir, S. L. Crouch and On behalf of the UK-Eire Lansoprazole Group

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00533.x

  20. Pharmacokinetics:Pharmacokinetic Differences Between Lansoprazole Enantiomers in Rats

    Journal of Pharmacy and Pharmacology

    Volume 50, Issue 11, November 1998, Pages: 1241–1245, KAZUHIKO ARIMORI, KAZUTO YASUDA, HISAKAZU KATSUKI and MASAHIRO NAKANO

    Article first published online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1998.tb03340.x